• SPX
  • $5,874.96
  • 1.59 %
  • $92.20
  • DJI
  • $43,537.76
  • 3.12 %
  • $1,315.87
  • N225
  • $39,480.67
  • 2.61 %
  • $1,005.77
  • FTSE
  • $8,151.77
  • -0.25 %
  • -$20.62
  • IXIC
  • $18,750.95
  • 1.69 %
  • $311.78
Crinetics Pharmaceuticals, Inc. (CRNX) Latest News

Crinetics Pharmaceuticals, Inc. (CRNX) Latest News

NASDAQ Currency in USD Disclaimer

Stock Price

$60.11

$2.3

(3.97%)

Day's range
$59.17
Day's range
$60.69

Latest News of CRNX

We Think Crinetics Pharmaceuticals (NASDAQ:CRNX) Can Afford To Drive Business Growth

By Yahoo! Finance | 2 months ago

Investors are attracted to unprofitable companies like Crinetics Pharmaceuticals despite risks. Analyzing its cash burn and runway, shareholders can assess its financial health and potential for growt...

Insider Sale at Crinetics Pharmaceuticals Inc (CRNX): Chief Scientific Officer Stephen Betz ...

By Yahoo! Finance | 4 months ago

Crinetics Pharmaceuticals focuses on rare endocrine diseases and tumors. Shares were sold at $43.86 each, totaling $131,580, amid a $3.53 billion market cap. Insider Stephen Betz sold 24,000 shares in...

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.